Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Alkermes logo
AlkermesALKS
$7.58M+20.4%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$628K+38.3%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$2.43M+3.5%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$58.8M+25.0%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$11.79M+3.7%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$446K+8.8%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s operating lease liabilities (current)?
Harmony Biosciences Holdings, Inc. (HRMY) reported operating lease liabilities (current) of $1.27M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s operating lease liabilities (current) changed year-over-year?
Harmony Biosciences Holdings, Inc.'s operating lease liabilities (current) increased by 10.4% year-over-year, from $1.15M to $1.27M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s operating lease liabilities (current)?
Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s operating lease liabilities (current) has grown at a -8.4% compound annual growth rate (CAGR), from $1.53M to $1.07M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.